Stock Alert: DexCom Down 6%

(RTTNews) - Shares of DexCom, Inc. (DXCM), a medical device company, are losing almost 6 percent or $24.77 in Tuesday's morning trade at $393.23.

U.S. stocks are little changed on Tuesday following the sell-off seen in the previous sesion, which came amid concerns about a renewed spike in coronavirus cases. Investors remained cautious as they monitored corporate earnings results and merger news.

Monday, DexCom said that Rick Doubleday, the company's executive vice president and chief commercial officer, will retire at the end of 2020 in order to spend more time with his family. Rick joined DexCom in 2009.

DexCom also announced preliminary third-quarter revenues of $500.9 million, representing growth of 26 percent year over year. Analysts polled by Thomson Reuters have a consensus revenue estimate of $476.75 million. DexCom will provide a full presentation of its quarterly results on Tuesday, October 27.

DexCom has traded in a range of $149.46 to $456.23 in the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More